Mochi Health vs PlushCare
Side-by-side on pricing, clinical support, insurance coverage, and medication options for 2026.
| Mochi Health | PlushCare | |
|---|---|---|
| Starting price | $99/mo | $139/mo |
| Insurance support | Yes | Yes |
| Clinical support | Medium (provider check-ins) | Medium (provider check-ins) |
| Medication forms | Injection, Pill | Injection |
Both are insurance-first programs, which puts them in a narrower peer group than the cash-pay options. Plushcare's strength is its in-network relationships with most major commercial plans — if you have Aetna, Blue Cross, or United, the visit itself is often fully covered. Mochi focuses more on the drug-coverage side: running PAs and targeting $0 copay on Zepbound or Wegovy.
Who wins on what
Insurance angle: visit vs. drug
Insurance coverage has two distinct pieces: the visit (who sees you) and the drug (who pays for the medication). Plushcare is built around the visit side — it operates as in-network telehealth with most large commercial insurers, so the $139 sticker price often drops to a copay ($0–$25) depending on plan. Drug coverage is a separate question Plushcare will help run, but it's not the core differentiator.
Mochi's model flips that: the $99 monthly fee is the program, and the heavy investment is in chasing GLP-1 PAs — the coverage fight that turns a $349 cash-pay drug into a $0–$25 covered drug. For patients whose main cost is the medication, not the visit, Mochi's focus pays off more per dollar.
Which program for which patient
Pick Plushcare if you have a large-commercial plan with telehealth benefits and want a program that can also handle adjacent issues (BP, cholesterol, hormones). It behaves more like a primary-care relationship with GLP-1 prescribing inside it.
Pick Mochi Health if you primarily care about getting the lowest total cost on the medication itself and want a team whose entire workflow is tuned for GLP-1 PA conversion. Mochi also offers both injection and pill options, which Plushcare does not emphasize.
Frequently asked questions
Does Plushcare actually save money vs. Mochi?
It depends on where your cost is concentrated. If your plan makes GLP-1 drug coverage straightforward but charges for telehealth, Plushcare's in-network visit saves more. If the drug itself is the hard part to get covered, Mochi's PA team saves more.
Can either program handle diabetes or hypertension too?
Plushcare is structured as general telehealth and can prescribe across conditions, making continuity easier. Mochi is GLP-1-focused; you'd need a separate provider for unrelated conditions.
How does each handle Medicare?
Neither is especially strong on Medicare for weight management, since Medicare Part D doesn't cover GLP-1s for obesity (only for diabetes and, narrowly, Wegovy for CV risk). Patients on Medicare should ask each program how they handle that gap.
Not sure which is right for you? Take the Sherpa Matcher — it accounts for your goals, budget, and insurance in 60 seconds.